Orexo AB
STO:ORX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orexo AB
STO:ORX
|
SE |
|
O
|
OSI Systems Inc
XMUN:OS2
|
US |
|
L
|
LSI Industries Inc
F:LS2
|
US |
|
M
|
ManpowerGroup Inc
XMUN:MPW
|
US |
|
Waters Corp
NYSE:WAT
|
US |
|
A
|
Aptargroup Inc
F:AGT
|
US |
|
American Electric Power Company Inc
NASDAQ:AEP
|
US |
|
B
|
Billerud AB (publ)
F:BNF
|
SE |
Intrinsic Value
Is ORX undervalued or overvalued?
See the intrinsic value estimate for
Orexo AB and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Orexo AB Does
Orexo AB is a Swedish specialty pharmaceutical company that makes and sells medicines, mainly for opioid use disorder and other conditions where drug delivery matters. Its best-known product is Zubsolv, a prescription tablet that doctors use to help patients manage opioid dependence. The company also develops new formulations and delivery technologies that can make medicines easier to take or more reliable to use.
- Headquarters
- Sweden SE
- Employees
- 65
- IPO date
- Nov 9, 2005
Revenue & Expenses Breakdown
Orexo AB
Earnings Waterfall
Orexo AB
The intrinsic value for
Orexo AB (ORX) under the Base Case is hidden SEK.
Compared with the current market price of 1.498 SEK, the stock appears hidden.